Cornerstone Pharmaceuticals, Inc.
PrivateLast Round
Recap
Mar 13, 2024
Est. Valuation
$125M
Total Funding Raised
$39.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cornerstone Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Monmouth Junction, New Jersey. Its latest recorded funding round was a VC Round in January 2019.
Cornerstone Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops metabolic oncology therapeutics designed to treat cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cornerstone Pharmaceuticals, Inc. Comparables
Compare Cornerstone Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advanced BioDesign | 78% | |
| ImmunoMet Therapeutics | 78% | |
| Faeth Therapeutics | 75% |
For institutional investors. Book with your work email.
Cornerstone Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Recap | Mar 13, 2024 | ||||
| VC Round | Jan 23, 2019 | ||||
| Series D | Sep 7, 2018 | ||||
| Series C | Sep 19, 2016 | ||||
| Convertible Debt | Sep 16, 2016 | ||||
Series B Extension | Jan 26, 2010 |
For institutional investors. Book with your work email.
Cornerstone Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CS Pharma Holdings, LLC | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 151% MoM.
- Jun 21, 2026
Monthly visitors increased 75% MoM.
For institutional investors. Book with your work email.
Cornerstone Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cornerstone Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Cornerstone Pharmaceuticals, Inc. a public or private company?
Cornerstone Pharmaceuticals, Inc. is a private company.
What is the current stock price of Cornerstone Pharmaceuticals, Inc.?
Cornerstone Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Cornerstone Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cornerstone Pharmaceuticals, Inc. worth (valuation)?
Cornerstone Pharmaceuticals, Inc.'s valuation is estimated at $125.0M based on funding round data.
Can I buy Cornerstone Pharmaceuticals, Inc. stock?
Cornerstone Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cornerstone Pharmaceuticals, Inc.'s last funding round?
Cornerstone Pharmaceuticals, Inc.'s most recent funding round was Recap on March 13, 2024.
Who are the main investors in Cornerstone Pharmaceuticals, Inc.?
Key investors in Cornerstone Pharmaceuticals, Inc. include CS Pharma Holdings, LLC.
Will Cornerstone Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Cornerstone Pharmaceuticals, Inc..
How can I track Cornerstone Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Cornerstone Pharmaceuticals, Inc.'s shares on secondary markets.